Construction and in vitro properties of SIVmac mutants with deletions in nonessential genes [corrected and republished article originally printed in AIDS Res Hum Retroviruses 1994 Apr;10(4):333-42] NLM AIDSLINE Important note: Information in this article was accurate in 1995. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Construction and in vitro properties of SIVmac mutants with deletions in nonessential genes [corrected and republished article originally printed in AIDS Res Hum Retroviruses 1994 Apr;10(4):333-42]

AIDS Res Hum Retroviruses. 1994 May;10(5):607-16. Unique Identifier : AIDSLINE MED/95000934
Gibbs JS; Regier DA; Desrosiers RC; Harvard Medical School, New England Regional Primate Research; Center, Southborough, Massachusetts 01772-9102.


Abstract: The so-called nonessential genes of primate lentiviruses can be deleted without abrogating the ability of virus to replicate under at least some cell culture conditions. In SIVmac, these genes are vif, vpx, vpr, and nef. Sequences in the upstream region of U3 in the LTR have also been shown to be dispensable for replication in cell culture. We report here the construction and characterization of a panel of 40 single and combination deletion mutants derived from the pathogenic molecular clone SIVmac239. Deletion of the vpr gene caused little or no change in the growth properties of SIVmac239 in CEMx174 cells, in rhesus monkey peripheral blood mononuclear cells (PBMCs), or in rhesus monkey alveolar macrophages. Deletion of the vpx gene resulted in a greatly reduced rate of replication of the virus in the primary PBMC and macrophage cultures, but no significant reduction in replication of the virus in CEMx174 cells. Deletion of the vpx gene appeared to have a greater effect on virus replication in macrophages than in PBMCs. Deletion of the vif gene caused a dramatic reduction in replication in all cell types tested. However, even delta 5, which contains deletions in all five targeted regions (vif, vpx, vpr, nef, and U3), can still replicate in CEMx174 cells albeit with greatly delayed kinetics. Deletion of nef, alone or in combination with deletions in U3 and vpr, had no observable effect on replication of the virus in any of the cells tested. Because the disease induced by the parental SIVmac239 clone in rhesus monkeys has been well characterized and is remarkably similar to AIDS in humans, this collection of mutants will be useful for relating in vitro properties and gene function with in vivo pathogenic potential.
Keywords: Amino Acid Sequence Animal Base Sequence Cell Line DNA Primers/GENETICS DNA, Viral/GENETICS Gene Products, env/*GENETICS Genes, nef Genes, vif Genes, vpr Genes, vpu *Genes, Viral Leukocytes, Mononuclear/MICROBIOLOGY Macaca mulatta Macrophages, Alveolar/MICROBIOLOGY Molecular Sequence Data Mutagenesis Retroviridae Proteins, Oncogenic/*GENETICS *Sequence Deletion Support, U.S. Gov't, P.H.S. SIV/*GENETICS/PHYSIOLOGY Viral Fusion Proteins/*GENETICS Virus Replication/GENETICS CORRECTED AND REPUBLISHED ARTICLE JOURNAL ARTICLEKWDaminoacidsequenceanimalbasesequencecelllinednaprimers/geneticsdna,viral/geneticsgeneproducts,env/KWDgeneticsgenes,nefgenes,vifgenes,vprgenes,vpuKWDgenes,viralleukocytes,mononuclear/microbiologymacacamulattamacrophages,alveolar/microbiologymolecularsequencedatamutagenesisretroviridaeproteins,oncogenic/KWDgeneticsKWDsequencedeletionsupport,uKWDsKWDgov't,pKWDhKWDsKWDsiv/KWDgenetics/physiologyviralfusionproteins/KWDgeneticsvirusreplication/geneticscorrectedandrepublishedarticlejournalarticle
950130
M9510837

Copyright © 1995 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1995. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1995. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .